Navigation Links
BSGI Molecular Breast Imaging Proves Equivalent to MRI in Breast Cancer Patient Management
Date:7/10/2012

NEWPORT NEWS, Va., July 10, 2012 /PRNewswire/ -- According to a new study presented at the 2012 American Society of Breast Surgeons, Molecular Breast Imaging (MBI), also known as BSGI, is equivalent to MRI in detecting breast cancer. Although both MBI/BSGI and MRI are capable of detecting cancers missed by mammography and ultrasound, the MBI/BSGI procedure can be conducted for about 1/3 the cost of an MRI examination.

In this study of 276 patients at George Washington University Hospital, the MBI/BSGI procedure was conducted with the Dilon 6800® Gamma Camera. The number of patients who underwent a MBI/BSGI procedure was twice those of MRI and the authors concluded that there was no statistically significant difference between the sensitivity or specificity of the two modalities. According to one of the authors, Dr. Christine Teal from the Department of Surgery at George Washington University Hospital, "MBI/BSGI continuously proves to be a very important diagnostic tool in our facility by providing outstanding results in detecting additional cancers. MBI clearly indicated a change in patient management for a greater number of patients than did MRI."

MRI cannot be performed on patients with metal or electronic implants, or those with claustrophobia. In addition, MRI utilizes a contrast agent that has been reported to cause adverse reactions in a very small number of patients, especially those with insufficient kidney function. Such patients have no difficulty having a MBI/BSGI exam. 

About Dilon Diagnostics

Dilon Diagnostics®, a brand of Dilon Technologies® Inc., is bringing innovative new medical imaging products to market. Dilon's cornerstone product, the Dilon 6800®, is a high-resolution, small field-of-view gamma camera, optimized to perform MBI/BSGI, a molecular breast imaging procedure which images the metabolic activity of breast lesions through radiotracer uptake. Many leading medical centers around the country are now offering MBI/BSGI to their patients, such as Cornell University Medical Center, New York and George Washington University Medical Center, Washington, D.C. As part of Dilon's commitment to offering complete solutions, the new declipseSPECT is the first intra-operative handheld 3D image viewing and navigation solution with applications in SLNB breast, I-125 Seed Localization, SLNB Head and Neck etc. For more information on Dilon Technologies® please visit www.molecularbreastimaging.com

Media contact: Pjerin Luli
P: 757-269-4910
E: pluli@dilon.com


'/>"/>
SOURCE Dilon Diagnostics
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. QIAGEN and Cardinal Health Collaborate to Offer Molecular Diagnostic Products to Smaller and Mid-sized U.S. Hospitals
2. Novelos Therapeutics Successfully Completes First Cohort In Phase 1b Solid Tumor Trial With I-131-CLR1404 (HOT) Cancer-Targeted Molecular Radiotherapeutic
3. Frost & Sullivan: Expanding Sample Prep Market Supports Growth Trends in Molecular Diagnostics Markets
4. QIAGEN Unveils Initiative to Create Next-Generation Sequencing Portfolio for use in Clinical Research and Molecular Diagnostics
5. The 2012 US Molecular Diagnostics Market
6. BSGI Molecular Breast Imaging Provides Better Results than MRI for Cancer Patients with Dense Breasts
7. Latest Findings in Breastfeeding Science Presented at Medelas 7th International Breastfeeding and Lactation Symposium
8. Evergreen Healthcare Foundation Gala Raises Nearly $1.1 Million to Benefit Breast Health Center
9. Generex Announces Presentations of Antigen Express AE37 Breast Cancer Vaccine Data at ASCO 2012
10. Generex Announces New Members of Antigen Express Scientific Advisory Board for the AE37 Breast Cancer Vaccine
11. Medical Tactile, Inc. Announces a 3G-Wireless System for Breast Cancer Screening
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/2/2016)... , May 2, 2016 ... reach USD 11.1 billion by 2024, according to ... Inc. Major drivers of the sonography market include ... and government recommendations for periodic ultrasound screenings of ... (Logo: http://photos.prnewswire.com/prnh/20150105/723757 ) High ...
(Date:4/29/2016)... 29, 2016 ReportsnReports.com adds ... market research report that provides an overview of ... at various stages, therapeutics assessment by drug target, ... and molecule type, along with latest updates, and ... key players involved in the therapeutic development for ...
(Date:4/29/2016)... , April 29, 2016 ... Directeur Financier Sanofi, leader ... publie ses résultats pour le premier ... Groupe, Jérôme Contamine, commente les résultats ... les perspectives pour le reste de ...
Breaking Medicine Technology:
(Date:5/3/2016)... ... ... In April, Amerec launched a new website designed with optimal user experience in ... sauna solutions. , First, the Amerec website has been redesigned to be easier to ... features, especially the Steam Builder Tool , to both mobile and desktop devices. ...
(Date:5/3/2016)... , ... May 03, 2016 , ... For over 23 ... medical providers to build the leading network of doctors and therapists treating personal injury ... founder of the distinguished Bay Chiropractic and Rehabilitation in Santa Monica, Doctors ...
(Date:5/3/2016)... ... ... for the 31st annual AIDS Walk Boston & 5K Run , which will take ... regularly draws thousands of participants, making it AIDS Action Committee’s largest annual fundraiser. The Walk ... Track & Field Association. , The AIDS Walk & 5K Run will begin and ...
(Date:5/3/2016)... Santa Monica, California (PRWEB) , ... May 03, 2016 , ... ... cosmetic surgery practice in late 2014, incorporating the injectable filler into his menu ... journeys of aesthetic transformation. Now, more than a year later, he’s still improving his ...
(Date:5/3/2016)... ... May 03, 2016 , ... University of the People, ... launch of its Associates and Bachelor's degrees in Health Studies. Leading figures are ... Dr. Torsten N. Wiesel; Chairman and CEO of Fortune 500® company Henry Schein, ...
Breaking Medicine News(10 mins):